← Leaderboards
Edward S. Horton
Beth Israel Deaconess Medical Center
$8,231,247
Attributed
$8,597,853
Total exposure
24
Grants
14
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1M · FY2005–17$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
Funding mix
By agency
NIH$8,597,853 · 24
By mechanism
U01$5,468,467 · 1
M01$2,396,173 · 22
R01$733,213 · 1
Top collaborators
- Emily Oken2 shared
Most similar at Beth Israel Deaconess Medical Center
Same institution · by research overlap
- Gregory A Wellenius$8,936,538
- Ellen P McCarthy$1,041,906
- Long Ngo$216,928
- Hilary Laura Zetlen$86,004
Others in their field
Top investigators on “Diabetes Mellitus”
- Jeffrey P Krischer · University Of South Florida$608,226,434
- Kathryn Hirst · Caritas St. Elizabeth'S Medical Center$177,347,135
- John M Lachin · George Washington University$155,262,668
- David M Nathan · Massachusetts Institute Of Technology$142,806,023
- Judith S Hochman · New York University School Of Medicine$100,149,457
- Jose A Luchsinger · Columbia University Health Sciences$75,551,718
Research focus
Diabetes MellitusLifestyle InterventionCardiovascular DiseasesMetforminCardiovascular Disorder RiskFundingDiabetes Prevention ProgramPlacebosFollow-UpRisk FactorsAffectLife StylePreventDiabetes PreventionCohortDesignIncidenceGrantResourcesObesityOutcome StudyNon-Insulin-Dependent Diabetes MellitusLong-Term EffectsAtherosclerosis
Grant awards (44)
07/22 Diabetes Prevention Program Outcomes Study (DPPOS)Phase 3 - Research Project$315,265
U01 · FY2017 · DK · contact PI
Longitudinal Association of PFCs with Obesity, Diabetes, and Metabolic Syndrome$356,441
R01 · FY2016 · ES
07/22 Diabetes Prevention Program Outcomes Study (DPPOS)Phase 3 - Research Project$248,250
U01 · FY2016 · DK · contact PI
07/22 Diabetes Prevention Program Outcomes Study (DPPOS)Phase 3 - Research Project$47,995
U01 · FY2016 · DK · contact PI
07/22 Diabetes Prevention Program Outcomes Study (DPPOS)Phase 3 - Research Project$29,476
U01 · FY2016 · DK · contact PI
Longitudinal Association of PFCs with Obesity, Diabetes, and Metabolic Syndrome$376,772
R01 · FY2015 · ES
DPPOS Follow-Up$236,708
U01 · FY2015 · DK · contact PI
Post-DPP Follow-Up Study$428,877
U01 · FY2014 · DK · contact PI
Post-DPP Follow-Up Study$420,126
U01 · FY2013 · DK · contact PI
Post-DPP Follow-Up Study$371,468
U01 · FY2012 · DK · contact PI
Post-DPP Follow-Up Study$530,226
U01 · FY2011 · DK · contact PI
Post-DPP Follow-Up Study$487,896
U01 · FY2010 · DK · contact PI
Post-DPP Follow-Up Study$477,975
U01 · FY2009 · DK · contact PI
Post-DPP Follow-up Study$413,372
U01 · FY2008 · DK · contact PI
CLINICAL TRIAL: LOOKAHEAD STUDY$28,774
M01 · FY2008 · RR · contact PI
DIABETES PREVENTION PROGRAM OUTCOMES STUDY (DPPOS)$14,282
M01 · FY2008 · RR · contact PI
MEAN A1C$11,819
M01 · FY2008 · RR · contact PI
THE EFFECTS OF EXENATIDE TO LANTUS INSULIN ON VASCULAR FUNCTION$8,372
M01 · FY2008 · RR · contact PI
CARDIOVASCULAR EFFECTS OF AIR POLLUTION IN DIABETES$7,035
M01 · FY2008 · RR · contact PI
LOOKAHEAD STUDY$320,594
M01 · FY2007 · RR · contact PI
MEAN A1C$180,261
M01 · FY2007 · RR · contact PI
Post-DPP Follow-up Study$160,249
U01 · FY2007 · DK · contact PI
DIABETES PREVENTION PROGRAM OUTCOMES STUDY (DPPOS)$128,590
M01 · FY2007 · RR · contact PI
THE EFFECTS OF EXENATIDE TO LANTUS INSULIN ON VASCULAR FUNCTION$45,798
M01 · FY2007 · RR · contact PI
CARDIOVASCULAR EFFECTS OF AIR POLLUTION IN DIABETES$23,485
M01 · FY2007 · RR · contact PI
Post-DPP Follow-up Study$436,929
U01 · FY2006 · DK · contact PI
LOOKAHEAD STUDY$320,236
M01 · FY2006 · RR · contact PI
DIABETES PREVENTION PROGRAM OUTCOMES STUDY (DPPOS)$102,556
M01 · FY2006 · RR · contact PI
ETHNIC DIFFERENCES IN ARTERIAL STIFFNESS- METABOLIC SYNDROME & CARDIO MARKERS$93,005
M01 · FY2006 · RR · contact PI
Post-DPP Follow-up Study$431,935
U01 · FY2005 · DK
LOOKAHEAD STUDY$274,864
M01 · FY2005 · RR
DIABETES PREVENTION PROGRAM OUTCOMES STUDY (DPPOS)$132,426
M01 · FY2005 · RR
EFFECTS OF PIOGLITAZONE ON PANCREATIC B-CELL FUNCTION AND VASCULAR REACTIVITY$52,789
M01 · FY2005 · RR
EFFECTS OF N-ACETYL-CYSTEINE ON ENDOTHELIAL FUNCTION IN PATIENTS W/ T2 DIABETES$52,333
M01 · FY2005 · RR
ARTERIAL STIFFNESS IN HEALTHY SUBJECTS, METABOLIC SYNDROME AND DIABETES$50,513
M01 · FY2005 · RR
SURGICAL VISCERAL FAT REDUCTION BY OMENTECTOMY$4,096
M01 · FY2005 · RR
ETHNIC DIFFERENCES IN ARTERIAL STIFFNESS- METABOLIC SYNDROME &CARDIO MARKERS$2,730
M01 · FY2005 · RR
Post-DPP Follow-up Study$431,720
U01 · FY2004 · DK
Look AHEAD study$298,768
M01 · FY2004 · RR
Effects of Pioglitazone on Pancreatic B-Cell Function and Vascular Reactivity$118,058
M01 · FY2004 · RR
DPPOS$114,951
M01 · FY2004 · RR
Endothelial Function Following Hypertensive Pregnancy$3,624
M01 · FY2004 · RR
Surgical Visceral Fat Reduction by Omentectomy$3,624
M01 · FY2004 · RR
Effect of Angiotensin Converting Enzyme Quinapril on Endothelial Function$2,590
M01 · FY2004 · RR